Literature DB >> 25985850

Development of a conceptual model evaluating the humanistic and economic burden of Crohn's disease: implications for patient-reported outcomes measurement and economic evaluation.

Adam Gater1, Helen Kitchen, Louise Heron, Catherine Pollard, Jonas Håkan-Bloch, Lise Højbjerre, Brian Bekker Hansen, Martin Strandberg-Larsen.   

Abstract

The primary objective of this review is to develop a conceptual model for Crohn's disease (CD) outlining the disease burden for patients, healthcare systems and wider society, as reported in the scientific literature. A search was conducted using MEDLINE, PsycINFO, EconLit, Health Economic Evaluation Database and Centre for Reviews and Dissemination databases. Patient-reported outcome (PRO) measures widely used in CD were reviewed according to the US FDA PRO Guidance for Industry. The resulting conceptual model highlights the characterization of CD by gastrointestinal disturbances, extra-intestinal and systemic symptoms. These symptoms impact physical functioning, ability to complete daily activities, emotional wellbeing, social functioning, sexual functioning and ability to work. Gaps in conceptual coverage and evidence of reliability and validity for some PRO measures were noted. Review findings also highlight the substantial direct and indirect costs associated with CD. Evidence from the literature confirms the substantial burden of CD to patients and wider society; however, future research is still needed to further understand burden from the perspective of patients and to accurately understand the economic burden of disease. Challenges with existing PRO measures also suggest the need for future research to refine or develop new measures.

Entities:  

Keywords:  Crohn’s disease; conceptual model; costs; health-related quality of life; patient-reported outcome measures

Mesh:

Year:  2015        PMID: 25985850     DOI: 10.1586/14737167.2015.1045883

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  4 in total

1.  Linkage between genotype and immunological phenotype in Crohn's disease.

Authors:  Gwenny M Fuhler; Kaushal Parikh; C Janneke van der Woude; Maikel P Peppelenbosch
Journal:  Ann Transl Med       Date:  2015-09

2.  Patient-Reported Outcomes in Oncology Drug Labeling in the United States: A Framework for Navigating Early Challenges.

Authors:  Alan L Shields; Yanni Hao; Meaghan Krohe; Andrew Yaworsky; Iyar Mazar; Catherine Foley; Faisal Mehmed; Denise Globe
Journal:  Am Health Drug Benefits       Date:  2016-06

3.  Body Mass Index and Disease Activity Are Associated With Moderate to Severe Disability in Crohn's Disease: A Cross-Sectional Study in Shanghai.

Authors:  DongSheng Bian; Yongmei Jiang; Yubei Gu; Zirui He; Qi Chen; Yonghua Tang; Jie Zhong; Yongmei Shi
Journal:  Front Med (Lausanne)       Date:  2021-07-09

4.  Health-related quality of life among Chinese patients with Crohn's disease: a cross-sectional survey using the EQ-5D-5L.

Authors:  Ziyun Gao; Pei Wang; Jie Hong; Yuqing Yan; Tianying Tong; Bin Wu; Jun Hu; Zhenhua Wang
Journal:  Health Qual Life Outcomes       Date:  2022-04-12       Impact factor: 3.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.